Gerstein, H. C. (2019). Dulaglutide and renal outcomes in type 2 diabetes. An exploratory analysis of the REWIND randomised, placebo-controlled trial. The Lancet.
Chicago Style CitationGerstein, Hertzel C. Dulaglutide and Renal Outcomes in Type 2 Diabetes. An Exploratory Analysis of the REWIND Randomised, Placebo-controlled Trial. The Lancet, 2019.
MLA CitationGerstein, Hertzel C. Dulaglutide and Renal Outcomes in Type 2 Diabetes. An Exploratory Analysis of the REWIND Randomised, Placebo-controlled Trial. The Lancet, 2019.
Warning: These citations may not always be 100% accurate.